Authors’ reply—Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not

por Zwart, W.H., Dijkstra, E.A., Putter, H., Marijnen, C.A.M., Nilsson, P.J., van de Velde, C.J.H., van Etten, B., Hospers, G.A.P., Glimelius, B.
Publicado 2023

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer

por van der Vos, K. E., Vis, D. J., Nevedomskaya, E., Kim, Y., Choi, W., McConkey, D., Wessels, L. F. A., van Rhijn, B. W. G., Zwart, W., van der Heijden, M. S.
Publicado 2020

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer—results from the RAPIDO trial

por Dijkstra, E.A., Zwart, W.H., Nilsson, P.J., Putter, H., Roodvoets, A.G.H., Meershoek-Klein Kranenbarg, E., Frödin, J.E., Nygren, P., Østergaard, L., Kersten, C., Verbiené, I., Cervantes, A., Hendriks, M.P., Capdevila, J., Edhemovic, I., van de Velde, C.J.H., Marijnen, C.A.M., van Etten, B., Hospers, G.A.P., Glimelius, B.
Publicado 2023